It should never be administered intravenously by itself , because it contains no salts and is hypotonic
This is one of the safeguards that are set in place to retain the integrity of the genome by minimizing the mutation processes that are significant aging factors
It may support individuals dealing with chronic inflammation, low energy, skin dullness, toxin buildup, oxidative stress, brain fog, and overall immune weakness
PubMed Central, CASTEL, MONA, and JOHN F
FOXO4-DRI is studied within the senolytic compound class alongside navitoclax and quercetin analogs, with researchers using it as a peptide-based mechanistic comparator targeting the FOXO4-p53 axis specifically
PubMed laboratory research record [PMID: 6271246] PubMed record related to this compound for laboratory literature review